Esora Tablet 20 mg (Esomeprazole Magnesium Dihydrate)

Adult dosage

This medication should be swallowed with liquids such as water and should not be chewed or crushed. 1. Gastroesophageal reflux disease (GERD) - Treatment of erosive esophagitis: 40 mg once daily for 4 weeks - If esophagitis is untreated or symptoms persist, an additional 4 weeks of treatment - Maintenance therapy to prevent recurrence of esophagitis: 20 mg once daily - Treatment of symptoms of gastroesophageal reflux disease without esophagitis: once daily,

Children's dosage

Adolescents aged 12 years and older - Treatment of gastroesophageal reflux disease (GERD) erosive esophagitis: 40 mg once daily for 4 weeks - If esophagitis is untreated or symptoms persist, an additional 4 weeks of treatment

This medication should not be administered to patients with known specific allergic reactions. For instance, if there is a hypersensitivity to this medication or its components, or if there was a history of allergy to benzimidazole derivatives. Additionally, this medication may cause hypersensitivity reactions when used in combination with certain antibiotics, so patients with allergies to penicillin or macrolide antibiotics should exercise caution. Rarely, various side effects such as blood disorders, allergic reactions, hypomagnesemia may occur during the use of this medication, so if any unusual symptoms arise, immediate consultation with a physician should be sought. It is essential to undergo regular health check-ups during long-term use, particularly for those taking the medication for more than one year; regular blood tests, including magnesium levels, should be conducted. Since this medication suppresses gastric acid, it may promote bacterial growth in the stomach, so if diarrhea or symptoms of gastrointestinal infection persist, it should be reported to healthcare personnel. Also, patients with osteoporosis or those at risk of fractures may have an increased risk of fractures during long-term use of this medication, requiring appropriate monitoring, including bone density testing. This medication may interact with certain other drugs, therefore, current medications must be disclosed to a physician or pharmacist. Pregnant or breastfeeding women should consult with healthcare personnel before taking this medication, and it is advisable to avoid its use while breastfeeding. In case of overdose, there are no specific antidotes, and symptomatic treatment should be provided; keep the medication out of reach of children.

Serious side effects

Hives, severe swelling (angioedema, accompanied by systemic symptoms), chest tightness, difficulty breathing, cold sweat, paleness, anaphylactic reaction/shock, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, cough and fever associated respiratory symptoms

Mild side effects

Headache, dizziness, sensory disturbances, drowsiness, taste disorders, blurred vision, bronchospasm, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, increased liver enzymes, hepatitis, dermatitis, itching, rash, hair loss, photosensitivity, fractures, joint pain, muscle pain, muscle weakness, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, sternal pain

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu×2)